NasdaqGS - Delayed Quote
USD
Neumora Therapeutics, Inc. (NMRA)
2.0400
-0.0400
(-1.92%)
At close: April 10 at 4:00:01 PM EDT
2.0600
+0.0200
(+0.98%)
After hours: April 10 at 5:36:11 PM EDT
Trade NMRA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for NMRA
Chart does not reflect overnight price.
- Previous Close
2.0800 - Open
2.0900 - Bid 2.0100 x 400
- Ask 2.0500 x 1400
- Day's Range
2.0050 - 2.1400 - 52 Week Range
0.6110 - 3.6500 - Volume
765,719 - Avg. Volume
1,333,571 - Market Cap (intraday)
371.364M - Beta (5Y Monthly) 3.12
- PE Ratio (TTM)
-- - EPS (TTM)
-1.4500 - Earnings Date (est.) May 6, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.91
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease. In addition, the company's preclinical phase product includes NMRA-NMDA and NMRA-M4R for the treatment of Schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
www.neumoratx.comRecent News: NMRA
View More
Performance Overview: NMRA
Trailing total returns as of 4/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
NMRA
13.97%
S&P 500 (^GSPC)
0.42%
1-Year Return
NMRA
184.52%
S&P 500 (^GSPC)
29.40%
3-Year Return
NMRA
88.00%
S&P 500 (^GSPC)
65.90%
5-Year Return
NMRA
88.00%
S&P 500 (^GSPC)
65.11%
Earnings Trends: NMRA
View MoreAnalyst Insights: NMRA
View MoreStatistics: NMRA
View MoreValuation Measures
As of 4/10/2026
-
Market Cap
371.36M
-
Enterprise Value
243.84M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
3.58
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-58.11%
-
Return on Equity (ttm)
-121.21%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-236.93M
-
Diluted EPS (ttm)
-1.4500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
182.53M
-
Total Debt/Equity (mrq)
52.96%
-
Levered Free Cash Flow (ttm)
-115.71M
Compare To: NMRA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: NMRA
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
